Differential patterns of allelic loss in estrogen receptor-positive infiltrating lobular and ductal breast cancer-Reference-Cited by-同舟云学术

Differential patterns of allelic loss in estrogen receptor-positive infiltrating lobular and ductal breast cancer

Published:2008-12 Issue:12 Volume:47 Page:1049-1066
ISSN:1045-2257
Container-title:Genes, Chromosomes and Cancer
language:en
Short-container-title:Genes Chromosom. Cancer

Author:

Loo L. W. M.,Ton C.,Wang Y.-W.,Grove D. I.,Bouzek H.,Vartanian N.,Lin M.-G.,Yuan X.,Lawton T. L.,Daling J. R.,Malone K. E.,Li C. I.,Hsu L.,Porter P. L.

Publisher

Wiley

Subject

Cancer Research,Genetics

Reference51 articles.

1. Allelic loss of chromosomal arm 8p in breast cancer progression;Anbazhagan;Am J Pathol,1998

2. Immunohistochemical estrogen receptor determination in paraffin embedded tissue;Andersen;Cancer,1989

3. Loss of heterozygosity and microsatellite instability in ductal carcinoma in situ of the breast;Ando;Cancer Lett,2000

4. Infiltrating lobular carcinoma of the breast: Tumor characteristics and clinical outcome;Arpino;Breast Cancer Res Epub,2004

5. Characterization of interactions between PinX1 and human telomerase subunits hTERT and hTR;Banik;J Biol Chem,2004

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond the “3 Ps”: A critical appraisal of the non-endocrine manifestations of multiple endocrine neoplasia type 1;Frontiers in Endocrinology;2022-10-17

2. Association between genetic variants at 9p21 locus with risk of breast cancer: A systematic review and meta-analysis;Pathology - Research and Practice;2020-07

3. Loss of Heterozygosity (LOH) at 17p13 and 22q13 are Shared by Breast and Thyroid Carcinomas for Metastasis;Applied Immunohistochemistry & Molecular Morphology;2019-02

4. Role of columnar cell lesions in breast carcinogenesis: analysis of chromosome 16 copy number changes by multiplex ligation-dependent probe amplification;Modern Pathology;2018-07-05

5. Impact of CYP2D6 polymorphisms on endoxifen concentrations and breast cancer outcomes;The Pharmacogenomics Journal;2017-08-01